In conclusion, this pan-cancer analysis identifies p62/SQSTM1 as a conserved, clinically relevant regulator linking oncogenic metabolism (oxidative phosphorylation, ROS, mTORC1, UPR/MYC, and DNA-repair programs) to the tumor immune microenvironment. Here, MYC is linked to cancer.